First Time Loading...

Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 1.62 USD Market Closed
Updated: May 5, 2024

Enlivex Therapeutics Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enlivex Therapeutics Ltd
Cash from Operating Activities Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Cash from Operating Activities
-$23.5m
CAGR 3-Years
-29%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash from Operating Activities
-$2.8m
CAGR 3-Years
15%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cash from Operating Activities
$4.3m
CAGR 3-Years
-39%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cash from Operating Activities
-$76.4m
CAGR 3-Years
10%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash from Operating Activities
-$7.3m
CAGR 3-Years
12%
CAGR 5-Years
6%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cash from Operating Activities
-₪26.5m
CAGR 3-Years
-20%
CAGR 5-Years
-18%
CAGR 10-Years
-12%

See Also

What is Enlivex Therapeutics Ltd's Cash from Operating Activities?
Cash from Operating Activities
-23.5m USD

Based on the financial report for Dec 31, 2023, Enlivex Therapeutics Ltd's Cash from Operating Activities amounts to -23.5m USD.

What is Enlivex Therapeutics Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-49%

Over the last year, the Cash from Operating Activities growth was 2%. The average annual Cash from Operating Activities growth rates for Enlivex Therapeutics Ltd have been -29% over the past three years , -49% over the past five years .